Deciphera Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DECIPHERA PHARMS, and when can generic versions of DECIPHERA PHARMS drugs launch?
DECIPHERA PHARMS has one approved drug.
There are six US patents protecting DECIPHERA PHARMS drugs.
There are forty patent family members on DECIPHERA PHARMS drugs in twelve countries.
Summary for Deciphera Pharms
International Patents: | 40 |
US Patents: | 6 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Deciphera Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | RE48731 | See Plans and Pricing | See Plans and Pricing | ||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,185,535 | See Plans and Pricing | Y | See Plans and Pricing | |||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 10,966,966 | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Deciphera Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2664009 | See Plans and Pricing |
Australia | 2007296441 | See Plans and Pricing |
Eurasian Patent Organization | 026730 | See Plans and Pricing |
Japan | 5265550 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.